Innovator IBD 50 ETF (NYSEARCA:FFTY) Trading 2.5% Higher – Time to Buy?

Innovator IBD 50 ETF (NYSEARCA:FFTY)’s stock price shot up 2.5% during mid-day trading on Tuesday . The company traded as high as $38.12 and last traded at $38.04. 26,855 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 64,038 shares. The stock had previously closed at $37.12.

Innovator IBD 50 ETF Stock Up 2.5%

The firm has a market capitalization of $81.79 million, a PE ratio of 30.34 and a beta of 1.47. The business’s fifty day moving average price is $40.21 and its 200 day moving average price is $38.50.

Institutional Trading of Innovator IBD 50 ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. Kestra Advisory Services LLC acquired a new position in Innovator IBD 50 ETF in the fourth quarter valued at $72,000. Jane Street Group LLC acquired a new stake in Innovator IBD 50 ETF in the 4th quarter worth about $282,000. Advisory Services Network LLC acquired a new stake in Innovator IBD 50 ETF in the 3rd quarter worth about $43,000. JPMorgan Chase & Co. purchased a new stake in Innovator IBD 50 ETF in the 3rd quarter valued at about $478,000. Finally, Bank of America Corp DE grew its holdings in Innovator IBD 50 ETF by 307.2% in the 2nd quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock valued at $404,000 after buying an additional 9,391 shares during the period.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.